Leverone Jason A.

Leverone Jason A. is listed in filings as Chief Financial Officer at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR). The current snapshot covers public activity from Oct 8, 2024 to Jun 24, 2026. Reported amounts are shown as $1.3K to $122.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.